Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it has stronger technical capacities, stockpiles, and some systems in certain areas than before COVID-19. Preparedness is uneven, fragile, and vulnerable to funding instability, workforce shortages, political fragmentation, eroded public trust, and equity gaps. Recent policy shifts have introduced new risks of backsliding.[1]
Post-COVID Improvements and Strengths
The US ranked near or at the top of the Global Health Security (GHS) Index historically (e.g., ~75.9–83.5/100 in available assessments), reflecting strong theoretical capacities in prevention, detection, and response relative to most countries—though the index has limitations as a predictor of real-world outcomes, as COVID demonstrated.[2]
Key advances include:
These built on decades of post-9/11 and post-Ebola frameworks (e.g., PAHPA authorizations).
Persistent and Emerging Gaps
COVID-19 exposed major shortfalls despite high prep rankings: delayed testing/surveillance, supply chain failures, politicized communication, uneven healthcare surge capacity (hospital beds/staff historically lag peers), high excess mortality relative to peers (exacerbated by inequities, comorbidities, and social factors), and poor use of existing plans. Many analyses concluded the US was “no better prepared” in key governance/response areas shortly after.[6]
Ongoing issues include:
ASPR and CDC continue operational work (e.g., SNS support for jurisdictions, special pathogen networks, supply chain initiatives), and some animal health/FAD funding has increased, but these do not fully offset systemic pressures.
Overall Assessment and Path Forward
The US has improved technical tools and inventories and learned operational lessons, positioning it better than many nations and than its 2019–2020 baseline in labs, data, stockpiles, and some planning. However, it is not adequately prepared for a severe, novel, or multi-wave crisis due to implementation gaps, volatility in sustained investment/leadership, workforce fragility, trust/equity shortfalls, and coordination challenges. High GHS/JEE scores measure capacity on paper more than effective, equitable, rapid real-world execution under stress. Recent shifts (research prioritization away from certain platforms, global disengagement) heighten vulnerability just as threats like H5N1, measles, severe respiratory seasons, and overseas outbreaks (Ebola variants, hantavirus) persist.[9]
True readiness requires: stable multi-year funding (reauthorize/strengthen PAHPA and core grants); workforce rebuilding and retention; SLTT capacity-building; trust/equity investments (community engagement, paid leave, access); domestic supply chain resilience; transparent data-sharing and communication; regular exercises of plans; and balanced global engagement for early warning. Preparedness is continuous—complacency after each crisis has historically eroded gains. Without bipartisan commitment to these, another crisis would again reveal preventable failures.
Citations (9)
- https://www.tfah.org/report-details/ready-or-not-2026/
Backs: “Recent policy shifts have introduced new risks of backsliding.”
- https://ghsindex.org/country/united-states/
Backs: “The US ranked near or at the top of the Global Health Security (GHS) Index historically (e.g., ~75.9–83.5/100 in available assessments), reflecting strong theoretical capacities in prevention, detection, and response relative to most countries—though the index has limitations as a predictor of real-world outcomes, as…”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “ASPR continues managing SNS deployments for threats like H5N1, mpox, Marburg, and Ebola, and has emphasized jurisdictional stockpiles and supply chain resilience (e.g., strategic API reserves).”
- https://www.who.int/publications/i/item/9789240105409
Backs: “The 2024 WHO Joint External Evaluation (JEE, using a COVID-updated tool) found high capacities in many of 19 technical areas, such as detection (labs/surveillance often 90%+), biosafety/biosecurity, immunization aspects, and emergency response operations (some near 100%).”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “State-level strengths per Trust for America’s Health (TFAH) Ready or Not 2026 include widespread Nurse Licensure Compact adoption (41 states for cross-border staffing), public health/emergency management accreditation, and lab surge plans in nearly all states.”
- https://www.cidrap.umn.edu/covid-19/high-level-group-distills-failures-successes-us-covid-response
Backs: “Many analyses concluded the US was “no better prepared” in key governance/response areas shortly after.”
- https://www.kff.org/global-health-policy/the-trump-administrations-foreign-aid-review-status-of-global-health-security-pandemic-preparedness/
Backs: “Global retreats (WHO withdrawal completed ~2026, USAID dissolution/reorganization, reduced GHS foreign assistance) weaken early detection abroad that protects the US.”
- https://www.scientificamerican.com/article/the-world-is-less-prepared-for-a-pandemic-than-before-covid-heres-why/
Backs: “US performance on indicators like paid sick leave, immunization, and hospital readiness varies widely.”
- https://www.sej.org/publications/backgrounders/are-we-ready-next-pandemic
Backs: “Recent shifts (research prioritization away from certain platforms, global disengagement) heighten vulnerability just as threats like H5N1, measles, severe respiratory seasons, and overseas outbreaks (Ebola variants, hantavirus) persist.”